Page last updated: 2024-11-05

triclofos and Neonatal Abstinence Syndrome

triclofos has been researched along with Neonatal Abstinence Syndrome in 1 studies

triclofos: derivative 7 metabolic precursor of trichloroethanol; RN given refers to parent cpd; structure

Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.

Research Excerpts

ExcerptRelevanceReference
"To determine the neonatal outcome in the form of use of morphine and triclofos to treat the neonatal abstinence syndrome following maternal opiate use in late pregnancy."3.71Neonatal outcome following maternal opiate use in late pregnancy. ( Armstrong, D; Carrick, P; Lindow, SW; Ohadike, P; Pairaudeau, P; Sinha, C, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sinha, C1
Ohadike, P1
Carrick, P1
Pairaudeau, P1
Armstrong, D1
Lindow, SW1

Other Studies

1 other study available for triclofos and Neonatal Abstinence Syndrome

ArticleYear
Neonatal outcome following maternal opiate use in late pregnancy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2001, Volume: 74, Issue:3

    Topics: Analgesics, Opioid; Female; Heroin; Humans; Infant, Newborn; Morphine; Neonatal Abstinence Syndrome;

2001